drugset

drugset / Trial / NCT01433380

A Study To Evaluate PF-05175157 In Healthy Volunteers

NCT01433380 ↗

Phase 1 Completed 22 enrolled Pfizer

RandomizedCrossoverDouble-blindBasic science

Summary

The primary purpose of this study is to evaluate the pharmacodynamics of single oral doses of PF-05175157 in healthy volunteers

Timeline

Start: 2011-07
Primary completion: 2012-05
Completion: 2012-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PF-05175157	Small molecule	600 mg	Oral

Indications